Download Citation
Article Source:
Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI: Randomized, Placebo-Controlled Phase II Clinical Trial in Patients with Latent Tuberculosis Infection
Nell AS,
D’lom E,
Bouic P,
Sabaté M,
Bosser R,
et al.
(2014)
Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI: Randomized, Placebo-Controlled Phase II Clinical Trial in Patients with Latent Tuberculosis Infection.
PLOS ONE 9(2): e89612.
https://doi.org/10.1371/journal.pone.0089612